Related references
Note: Only part of the references are listed.Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis
Harald Hegen et al.
MULTIPLE SCLEROSIS JOURNAL (2023)
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
Jessica Castillo-Villalba et al.
FRONTIERS IN IMMUNOLOGY (2022)
K index utility as diagnostic and prognostic biomarker in the assessment of patients with suspected Multiple Sclerosis
Claudia Cutelle et al.
JOURNAL OF NEUROIMMUNOLOGY (2022)
The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria
Georgina Arrambide et al.
BRAIN (2022)
Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity
Klaus Berek et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis
Lorenzo Gaetani et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse
Manuel Salavisa et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Biomarkers in Multiple Sclerosis
Anu Paul et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
Katharine Harding et al.
JAMA NEUROLOGY (2019)
Kappa free light chains could predict early disease course in multiple sclerosis
D. Vecchio et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis
Daniel Ontaneda et al.
LANCET NEUROLOGY (2019)
Multiple sclerosis - a review
R. Dobson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
B-Cell Therapy for Multiple Sclerosis: Entering an Era
Ariele L. Greenfield et al.
ANNALS OF NEUROLOGY (2018)
Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis
Emma Rathbone et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Jorge Correale et al.
BRAIN (2017)
Prognostic value of free light chains lambda and kappa in early multiple sclerosis
Margarete M. Voortman et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Prognostic value of free light chains lambda and kappa in early multiple sclerosis
Margarete M. Voortman et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Free light chains: Eclectic multipurpose biomarker
Umberto Basile et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments
Ann Marie Weideman et al.
FRONTIERS IN NEUROLOGY (2017)
Multiple sclerosis: assay of free immunoglobulin light chains
D. B. Ramsden
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Defining secondary progressive multiple sclerosis
Johannes Lorscheider et al.
BRAIN (2016)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
Mar Tintore et al.
BRAIN (2015)
Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis
Gleb Makshakov et al.
PLOS ONE (2015)
Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS
Stefan Presslauer et al.
PLOS ONE (2014)
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
Makbule Senel et al.
PLOS ONE (2014)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
Birgit Obermeier et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
Avijit Ray et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
Colin A. Hutchison et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis
S Cepok et al.
BRAIN (2005)